HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Tian Selected Research

Tyrosine Kinase Inhibitors

4/2016Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network meta-analysis.
1/2015Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
1/2014Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
5/2012Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Tian Research Topics

Disease

91Neoplasms (Cancer)
04/2024 - 04/2006
22Breast Neoplasms (Breast Cancer)
02/2024 - 04/2007
15Inflammation (Inflammations)
09/2023 - 04/2006
14Atrial Fibrillation
11/2022 - 10/2008
12Multiple Myeloma
01/2023 - 01/2016
11Birth Weight (Birth Weights)
02/2023 - 02/2011
11Leukemia
01/2021 - 09/2009
10Neoplasm Metastasis (Metastasis)
06/2022 - 02/2013
10Nasopharyngeal Carcinoma
01/2020 - 01/2010
9Hypoxia (Hypoxemia)
01/2023 - 01/2018
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2011
8Infections
03/2024 - 10/2007
7Adenocarcinoma
02/2024 - 01/2014
7Atherosclerosis
01/2023 - 09/2006
7Body Weight (Weight, Body)
01/2021 - 07/2009
7Heart Failure
01/2021 - 03/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
05/2023 - 02/2013
6Carcinoma (Carcinomatosis)
11/2012 - 07/2006
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2020 - 10/2009
4Gestational Diabetes (Gestational Diabetes Mellitus)
01/2024 - 12/2020
4Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 01/2016
4Thrombocytopenia (Thrombopenia)
05/2023 - 09/2010
4Obesity
01/2023 - 03/2020
4Triple Negative Breast Neoplasms
03/2022 - 01/2017
4Lung Neoplasms (Lung Cancer)
01/2022 - 05/2012
4Lymphoma (Lymphomas)
12/2020 - 11/2014
4Hyperlipidemias (Hyperlipidemia)
01/2019 - 02/2005
4Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 11/2009
3Alzheimer Disease (Alzheimer's Disease)
04/2024 - 01/2022
3Non-alcoholic Fatty Liver Disease
04/2024 - 10/2023
3Stomach Neoplasms (Stomach Cancer)
03/2024 - 10/2010
3Coronary Disease (Coronary Heart Disease)
03/2024 - 07/2020
3Cardiomegaly (Heart Hypertrophy)
01/2024 - 08/2005
3Insulin Resistance
12/2023 - 01/2019
3Hepatitis
10/2023 - 10/2007
3Reperfusion Injury
10/2023 - 06/2020
3Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
10/2023 - 01/2019
3Dry Eye Syndromes (Dry Eye Syndrome)
09/2023 - 01/2020
3Infertility (Sterility)
04/2023 - 01/2018
3Pulmonary Hypertension
01/2023 - 01/2019
3Neuroinflammatory Diseases
01/2023 - 01/2016
3Vascular Remodeling
01/2023 - 01/2019
3Pre-Eclampsia (Preeclampsia)
01/2023 - 07/2018
3Necrosis
03/2022 - 09/2018

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2004
17Messenger RNA (mRNA)IBA
03/2024 - 04/2005
11LipidsIBA
04/2024 - 02/2005
9MicroRNAs (MicroRNA)IBA
03/2024 - 10/2010
9Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2007
81-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2022 - 07/2015
7CytokinesIBA
01/2023 - 10/2007
7DNA (Deoxyribonucleic Acid)IBA
04/2021 - 10/2009
6Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2024 - 01/2015
6Peptides (Polypeptides)IBA
01/2024 - 01/2014
6GoldIBA
05/2023 - 04/2015
6EnzymesIBA
01/2023 - 09/2009
6HDL LipoproteinsIBA
11/2020 - 02/2005
5Glucose (Dextrose)FDA LinkGeneric
01/2024 - 11/2021
5LigandsIBA
03/2023 - 07/2009
5Monoclonal AntibodiesIBA
01/2023 - 04/2006
5Oxygen (Dioxygen)IBA
01/2023 - 05/2018
5Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2016
5Photosensitizing Agents (Photosensitizers)IBA
06/2022 - 07/2015
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 01/2013
5AntibodiesIBA
01/2021 - 07/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 06/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 02/2012
4TOR Serine-Threonine KinasesIBA
01/2024 - 10/2010
4RNA (Ribonucleic Acid)IBA
01/2024 - 08/2022
4oxidized low density lipoproteinIBA
06/2023 - 01/2016
4ferric ferrocyanide (Prussian blue)FDA Link
03/2023 - 01/2014
4Bortezomib (Velcade)FDA Link
01/2023 - 02/2012
4ParaffinIBA
11/2022 - 06/2012
4Cisplatin (Platino)FDA LinkGeneric
09/2021 - 01/2016
4Therapeutic UsesIBA
09/2021 - 07/2008
4Lipoproteins (Lipoprotein)IBA
10/2020 - 09/2006
4Gefitinib (Iressa)FDA Link
04/2016 - 10/2011
4Tyrosine Kinase InhibitorsIBA
04/2016 - 05/2012
4CalciumIBA
11/2012 - 04/2006
3Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2024 - 03/2004
3Hormones (Hormone)IBA
12/2023 - 04/2023
3Capsules (Microcapsules)IBA
10/2023 - 10/2018
3Reactive Oxygen Species (Oxygen Radicals)IBA
09/2023 - 12/2021
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2023 - 01/2016
3AntigensIBA
03/2023 - 04/2006
3InterleukinsIBA
01/2023 - 09/2008
3Apolipoproteins E (ApoE)IBA
01/2023 - 02/2005
3Losartan (Cozaar)FDA LinkGeneric
10/2022 - 01/2019

Therapy/Procedure

52Therapeutics
03/2024 - 09/2011
22Drug Therapy (Chemotherapy)
01/2023 - 11/2009
14Photothermal Therapy
05/2023 - 01/2016
10Lasers (Laser)
05/2023 - 03/2007
8Precision Medicine
05/2023 - 06/2015
8Photochemotherapy (Photodynamic Therapy)
06/2022 - 07/2015
8Catheter Ablation
12/2020 - 10/2008
5Nanospheres
12/2021 - 11/2014
4Immunotherapy
03/2023 - 12/2019
4Stem Cell Transplantation
01/2023 - 05/2019
4Radiotherapy
01/2020 - 07/2008
4Intravenous Injections
01/2019 - 01/2014